Hazel M Aker - Net Worth and Insider Trading
Hazel M Aker Net Worth
The estimated net worth of Hazel M Aker is at least $22,050 dollars as of 2024-04-18. Hazel M Aker is the Legal Counsel of Oncternal Therapeutics Inc and owns about 2,564 shares of Oncternal Therapeutics Inc (ONCT) stock worth over $22,050. Details can be seen in Hazel M Aker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hazel M Aker has not made any transactions after 2020-07-21 and currently still holds the listed stock(s).
Transaction Summary of Hazel M Aker
Hazel M Aker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hazel M Aker owns 1 companies in total, including Oncternal Therapeutics Inc (ONCT) .
Click here to see the complete history of Hazel M Aker’s form 4 insider trades.
Insider Ownership Summary of Hazel M Aker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2020-07-21 | General Counsel |
Hazel M Aker Latest Holdings Summary
Hazel M Aker currently owns a total of 1 stock. Hazel M Aker owns 2,564 shares of Oncternal Therapeutics Inc (ONCT) as of July 21, 2020, with a value of $22,050.
Latest Holdings of Hazel M Aker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2020-07-21 | 2,564 | 8.60 | 22,050 |
Holding Weightings of Hazel M Aker
Hazel M Aker Form 4 Trading Tracker
According to the SEC Form 4 filings, Hazel M Aker has made a total of 1 transactions in Oncternal Therapeutics Inc (ONCT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Oncternal Therapeutics Inc is the acquisition of 2,099 shares on July 21, 2020, which cost Hazel M Aker around $99,893.
Insider Trading History of Hazel M Aker
- 1
Hazel M Aker Trading Performance
GuruFocus tracks the stock performance after each of Hazel M Aker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hazel M Aker is -34.25%. GuruFocus also compares Hazel M Aker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hazel M Aker within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hazel M Aker's insider trading performs compared to the benchmark.
Performance of Hazel M Aker
Average Return
77.17%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.91 | -34.25 | 117.72 | 77.17 | -32.71 | -43.84 |
| Relative Return to S&P 500(%) | 1.62 | -39.72 | 99.43 | 43.36 | -43.51 | -55.51 |
Hazel M Aker Ownership Network
Ownership Network List of Hazel M Aker
Ownership Network Relation of Hazel M Aker
Hazel M Aker Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
Hazel M Aker is the General Counsel of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, Hazel M Aker made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 150,000 shares made by James B Breitmeyer , and a net purchase of 30,000 shares made by Richard G Vincent .
In summary, during the past 3 months, insiders sold 980 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 10,980 shares, with a net purchase of 10,000 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 23,880 shares were bought by its insiders, resulting in a net purchase of 22,900 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
Hazel M Aker Mailing Address
Above is the net worth, insider trading, and ownership report for Hazel M Aker. You might contact Hazel M Aker via mailing address: C/o Cancer Vax Corp, 2110 Rutherford Road, Carlsbad Ca 92008.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
